Basic Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Apr 21, 2015; 21(15): 4555-4563
Published online Apr 21, 2015. doi: 10.3748/wjg.v21.i15.4555
Figure 4
Figure 4 Level of plasma interleukin-6 and myeloperoxidase activity in the pancreas. A: Plasma interleukin (IL)-6 level after treatment with wortmannin; B: Myeloperoxidase (MPO) activity in pancreatic tissue after treatment with wortmannin. cP < 0.05 vs the severe acute pancreatitis (SAP) group; eP < 0.05 vs the 5 mg/kg NaHS + SAP group; gP < 0.05 vs the 100 mg/kg NaHS + SAP group.